Status:
COMPLETED
Endocan Levels at Polycystic Ovary Syndrome and Periodontal Inflammation
Lead Sponsor:
Ebru Saglam
Collaborating Sponsors:
Ataturk University
Conditions:
Polycystic Ovary Syndrome
Inflammation Gum
Eligibility:
FEMALE
18-40 years
Brief Summary
Periodontal diseases are chronic inflammatory disease occurred by the interaction between pathogenic microorganism and the host defense. Polycystic ovary syndrome (PCOS) is a reproductive and metaboli...
Eligibility Criteria
Inclusion
- Newly diagnosed PCOS patients
- Never smokers
- Had no history of systemic disease
- BMI\<25 kg/m2
- Participants had ≥20 teeth present.
Exclusion
- Pregnancy
- Lactation
- Hemoglobin A1c (HbA1c) ≥ 6.5%
- 2-h oral glucose tolerance test (OGTT-2h) ≥200
- Cushing syndrome, non-classic congenital adrenal hyperplasia, hyperprolactinemia, thyroid dysfunction, and androgen-secreting tumors
- Using antibiotics and antiinflammatory within the past 6 months
- Periodontal treatment within the past 6 months
Key Trial Info
Start Date :
April 3 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2017
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT03264846
Start Date
April 3 2017
End Date
November 29 2017
Last Update
February 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebru Sağlam
Istanbul, Eyalet/Yerleşke, Turkey (Türkiye), 34668